Cargando…

The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments

BACKGROUND: The important role of lipoproteins, particularly low-density lipoprotein (LDL) and high-density lipoprotein (HDL), has been highly regarded among the known causes of cardiovascular disease (CVD). A wide range of risk factors may cause structural and functional changes in lipoprotein part...

Descripción completa

Detalles Bibliográficos
Autores principales: Moshtaghie, Elham, Nayeri, Hashem, Moshtaghie, Ali Asghar, Asgary, Sedigheh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931615/
https://www.ncbi.nlm.nih.gov/pubmed/36819838
http://dx.doi.org/10.48305/arya.v18i0.2319
_version_ 1784889284106387456
author Moshtaghie, Elham
Nayeri, Hashem
Moshtaghie, Ali Asghar
Asgary, Sedigheh
author_facet Moshtaghie, Elham
Nayeri, Hashem
Moshtaghie, Ali Asghar
Asgary, Sedigheh
author_sort Moshtaghie, Elham
collection PubMed
description BACKGROUND: The important role of lipoproteins, particularly low-density lipoprotein (LDL) and high-density lipoprotein (HDL), has been highly regarded among the known causes of cardiovascular disease (CVD). A wide range of risk factors may cause structural and functional changes in lipoprotein particles, resulting in deposition and formation of atherosclerotic plaques. Homocysteine is one of the most important risk factors in heart disease, and its atherosclerotic properties appear to be related to its intermediate metabolite called homocysteine thiolactone (HCTL). The major aim of the present investigation was to study the effect of HCTL in different concentrations (10, 50, and 100 μM) on paraoxonase and aryl esterase activities of purified human serum paraoxonase 1 (PON1) antioxidant enzyme related to HDL, as an extracellular hydrolyzing enzyme of HCTL. METHODS: In order to purify PON1 enzyme from human serum, three-step chromatographic methods including DEAE Sephadex A50, Sephadex G100, and DEAE Sephadex A50 were used. Protein concentration and paraoxonase and aryl esterase activities of each fraction were measured separately and the highest activities fractions were collected and subsequently pooled together for the next steps. Ultimately, both activities of PON1 in the presence of different concentrations of HCTL were measured in triplicate by spectrophotometry technique. RESULTS: HCTL at concentrations of 50 and 100 μM decreased both paraoxonase and aryl esterase activities (P < 0.05) in comparison with the control group, which is directly related to the increase in HCTL concentration. However, at a concentration of 10 μM HCTL, no significant difference was observed in both paraoxonase and aryl esterase activities compared to the control group. CONCLUSION: HCTL is a highly toxic and reactive compound that is produced in all cells. Extracellular enzyme PON1 causes its hydrolysis with high efficiency. The results obtained from the present study showed that paraoxonase and aryl esterase activities decreased in vitro in the presence of HCTL and therefore, HCTL may cause changing in the protein structure of this enzyme. Previous in vivo studies have also shown decrease of PON1 activity in patients with hyperhomocysteinemia.
format Online
Article
Text
id pubmed-9931615
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-99316152023-02-17 The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments Moshtaghie, Elham Nayeri, Hashem Moshtaghie, Ali Asghar Asgary, Sedigheh ARYA Atheroscler Original Article BACKGROUND: The important role of lipoproteins, particularly low-density lipoprotein (LDL) and high-density lipoprotein (HDL), has been highly regarded among the known causes of cardiovascular disease (CVD). A wide range of risk factors may cause structural and functional changes in lipoprotein particles, resulting in deposition and formation of atherosclerotic plaques. Homocysteine is one of the most important risk factors in heart disease, and its atherosclerotic properties appear to be related to its intermediate metabolite called homocysteine thiolactone (HCTL). The major aim of the present investigation was to study the effect of HCTL in different concentrations (10, 50, and 100 μM) on paraoxonase and aryl esterase activities of purified human serum paraoxonase 1 (PON1) antioxidant enzyme related to HDL, as an extracellular hydrolyzing enzyme of HCTL. METHODS: In order to purify PON1 enzyme from human serum, three-step chromatographic methods including DEAE Sephadex A50, Sephadex G100, and DEAE Sephadex A50 were used. Protein concentration and paraoxonase and aryl esterase activities of each fraction were measured separately and the highest activities fractions were collected and subsequently pooled together for the next steps. Ultimately, both activities of PON1 in the presence of different concentrations of HCTL were measured in triplicate by spectrophotometry technique. RESULTS: HCTL at concentrations of 50 and 100 μM decreased both paraoxonase and aryl esterase activities (P < 0.05) in comparison with the control group, which is directly related to the increase in HCTL concentration. However, at a concentration of 10 μM HCTL, no significant difference was observed in both paraoxonase and aryl esterase activities compared to the control group. CONCLUSION: HCTL is a highly toxic and reactive compound that is produced in all cells. Extracellular enzyme PON1 causes its hydrolysis with high efficiency. The results obtained from the present study showed that paraoxonase and aryl esterase activities decreased in vitro in the presence of HCTL and therefore, HCTL may cause changing in the protein structure of this enzyme. Previous in vivo studies have also shown decrease of PON1 activity in patients with hyperhomocysteinemia. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2022-03 /pmc/articles/PMC9931615/ /pubmed/36819838 http://dx.doi.org/10.48305/arya.v18i0.2319 Text en © 2022 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences https://creativecommons.org/licenses/by-nc/3.0/This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Moshtaghie, Elham
Nayeri, Hashem
Moshtaghie, Ali Asghar
Asgary, Sedigheh
The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
title The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
title_full The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
title_fullStr The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
title_full_unstemmed The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
title_short The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
title_sort effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931615/
https://www.ncbi.nlm.nih.gov/pubmed/36819838
http://dx.doi.org/10.48305/arya.v18i0.2319
work_keys_str_mv AT moshtaghieelham theeffectofhomocysteinethiolactoneonparaoxonaseandarylesteraseactivityofhumanserumpurifiedparaoxonase1invitroexperiments
AT nayerihashem theeffectofhomocysteinethiolactoneonparaoxonaseandarylesteraseactivityofhumanserumpurifiedparaoxonase1invitroexperiments
AT moshtaghiealiasghar theeffectofhomocysteinethiolactoneonparaoxonaseandarylesteraseactivityofhumanserumpurifiedparaoxonase1invitroexperiments
AT asgarysedigheh theeffectofhomocysteinethiolactoneonparaoxonaseandarylesteraseactivityofhumanserumpurifiedparaoxonase1invitroexperiments
AT moshtaghieelham effectofhomocysteinethiolactoneonparaoxonaseandarylesteraseactivityofhumanserumpurifiedparaoxonase1invitroexperiments
AT nayerihashem effectofhomocysteinethiolactoneonparaoxonaseandarylesteraseactivityofhumanserumpurifiedparaoxonase1invitroexperiments
AT moshtaghiealiasghar effectofhomocysteinethiolactoneonparaoxonaseandarylesteraseactivityofhumanserumpurifiedparaoxonase1invitroexperiments
AT asgarysedigheh effectofhomocysteinethiolactoneonparaoxonaseandarylesteraseactivityofhumanserumpurifiedparaoxonase1invitroexperiments